 - Prior to Day 1, patients must be on oral or subcutaneous methotrexate 10 mgweek and 25 mgweek for at least 12 weeks with a stable dose for at least 4 weeks and folate 5 mgweek for at least 6 weeks, and willing to continue on this regimen for the duration of the study. 